Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic and cerebral amyloidosis.

B Frangione1

  • 1New York University Medical Center, NY 10016.

Annals of Medicine
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Hereditary cerebral hemorrhage with amyloidosis (HCHWA) presents in Icelandic (HCHWA-I) and Dutch (HCHWA-D) types, both causing strokes. HCHWA-I involves a Cystatin C gene mutation, while HCHWA-D is linked to Alzheimer

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conformation as therapeutic target in the prionoses and other neurodegenerative conditions.

Methods in molecular medicine·2011
Same author

Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease.

Neuropathology and applied neurobiology·2008
Same author

Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study.

Neuropathology and applied neurobiology·2006
Same author

Genetic alterations of the BRI2 gene: familial British and Danish dementias.

Brain pathology (Zurich, Switzerland)·2006
Same author

Chromosome 13 dementias.

Cellular and molecular life sciences : CMLS·2005
Same author

Platelet microparticles as carriers of soluble Alzheimer's amyloid beta (sAbeta).

Annals of the New York Academy of Sciences·2002
Same journal

Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial.

Annals of medicine·2026
Same journal

Postoperative outcomes of on- vs off-pump CABG in patients with HFrEF: a nationwide cohort study in Taiwan.

Annals of medicine·2026
Same journal

Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal function.

Annals of medicine·2026
Same journal

Association of neutrophil percentage-to-albumin ratio with sepsis in infant.

Annals of medicine·2026
Same journal

Enhancing Hemoglobin Bart's hydrops fetalis syndrome prevention: a single-tube multiplex real-time PCR assay for the comprehensive detection of four significant α<sup>0</sup>-thalassemia deletions (--<sup>SEA</sup>, --<sup>THAI</sup>, --<sup>CR</sup>, and --<sup>SA</sup>) found in Thailand.

Annals of medicine·2026
Same journal

Association of non-insulin-based insulin resistance indices with the risk of aortic stenosis progression in patients with mild or moderate aortic stenosis.

Annals of medicine·2026
See all related articles

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Familial cerebral amyloid angiopathy (HCHWA) comprises Icelandic (HCHWA-I) and Dutch (HCHWA-D) types, characterized by brain amyloidosis and recurrent strokes.
  • Both HCHWA types are autosomal-dominant disorders affecting cerebral vasculature, leading to early mortality.
  • Despite clinical similarities, the amyloid protein composition differs between HCHWA-I and HCHWA-D.

Purpose of the Study:

  • To elucidate the distinct molecular origins of amyloid proteins in HCHWA-I and HCHWA-D.
  • To compare the amyloidogenic pathways in these two forms of hereditary cerebral amyloid angiopathy.

Main Methods:

  • Analysis of amyloid protein composition in HCHWA-I and HCHWA-D.
  • Genetic sequencing to identify mutations in HCHWA-I.

Related Experiment Videos

  • Biochemical characterization of beta-protein in HCHWA-D.

    • Main Results:

    • HCHWA-I amyloid protein is derived from a mutated Cystatin C gene (gamma trace).
    • HCHWA-D amyloid protein is related to the beta-protein found in Alzheimer's disease and Down syndrome.
    • HCHWA-D beta-protein sequence is shorter, suggesting specific proteolysis in vessel walls.

    Conclusions:

    • HCHWA-I and HCHWA-D result from distinct genetic and proteolytic mechanisms.
    • The findings highlight differential processing of amyloid precursors in cerebral vasculature.
    • Understanding these differences is crucial for diagnosing and potentially treating HCHWA subtypes.